1. The relative contribution of photons and positrons to skin dose in the handling of PET radiopharmaceuticals.
- Author
-
Marengo M and Rubow S
- Subjects
- Humans, Gallium Radioisotopes, Positron-Emission Tomography, Radiation Dosage, Radiopharmaceuticals, Electrons
- Abstract
Background: Despite recommendations to use syringe and vial shields to reduce exposure of the hands of staff when manipulating PET radiopharmaceuticals, operators sometimes prefer to work without shields, believing that the faster handling limits the equivalent dose. The aim of this work is to show that this approach does not properly consider the contribution of positrons to the dose., Materials and Methods: Using the Varskin+ code, skin doses were calculated for syringes of various sizes, filled with
18 F,11 C or68 Ga solution. Syringes without shielding, or shielded with 2 mm and 10 mm of tungsten were considered., Results: Dose rate values in mSv/s per MBq, averaged on a 1 cm2 surface at a depth of 0.07 mm were calculated for all the above conditions. For example, in the case of 3 mL18 F syringe at 1 mm from the skin, the dose rate without shielding is 1.32E-02 and 8.63E-04 for positrons and photons respectively. For11 C, the corresponding dose rates are 4.70E-02 and 8.90E-04 respectively, and for68 Ga, 8.52E-02 and 9.48E-04., Conclusions: Our results show that the dose due to positrons is the principal component of skin irradiation, by a factor of 3-100, depending on the conditions. The use of shields for syringes and vials is necessary to avoid unjustified skin exposures, that may challenge dose limits. In our opinion, automatic systems for dispensing and allowing injection with shielded syringes, or automatic injectors, are economically justified and should be adopted in PET., Competing Interests: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2023 Elsevier Ltd. All rights reserved.)- Published
- 2023
- Full Text
- View/download PDF